Search the Newsreel

Aclaris Therapeutics (NASDAQ:ACRS) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

GigaCloud outlines Q3 revenue of $375M-$400M as Europe GMV rises 66%

Earnings Call Insights: GigaCloud Technology Inc. (GCT) Q2 2026 MANAGEMENT VIEW * "Our second quarter demonstrated GigaCloud's resilience and adaptability." (Founder, Chairman & CEO Lei Wu) * "Despite ongoing pressure from across the broader furniture landscape, we delivered 28% revenue growth and the record …

Aclaris Therapeutics Inc earnings beat by $0.01, revenue topped estimates

Aclaris Therapeutics Inc (NASDAQ: ACRS) reported a second-quarter EPS of $-0.150, surpassing analyst estimates by $0.01. The company also exceeded revenue expectations, bringing in $1.6M against a consensus of $1.38M. Aclaris Therapeutics' stock has shown strong performance, increasing by 29.010% in the last three …

Aclaris Therapeutics Receives Fast Track Designation for Modzatinib for Moderate to Severe Lichen Planus

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has been granted Fast Track Designation by the FDA for its investigational drug modzatinib, intended for the treatment of moderate to severe lichen planus. This designation will expedite the development and review process for the therapy, which currently has …

Aclaris Therapeutics (ACRS) Releases Q2 2026 Earnings: Revenue Declines, Losses Narrow

FDA grants fast track status to Aclaris’ lichen planus drug By Investing.com

Aclaris Therapeutics Inc. (NASDAQ:ACRS) has received Fast Track Designation from the FDA for its drug modzatinib (ATI-2138) to treat moderate to severe lichen planus. This designation will accelerate the development and review process for the drug, which addresses an unmet medical need as there …

Photos: Oracle quietly builds riverfront greenway next to future East Bank campus

Oracle has constructed a riverfront park on the East Bank, offering a preview of the development planned for its upcoming $4.5 billion campus. This greenway is the initial component of a larger system intended to span the East Bank area. The article provides a …

Why Aclara Resources Inc stock is skyrocketing today

FMR LLC (SMG) discloses 4.1M-share position in Scotts Miracle-Gro common stock

FMR LLC has reported a beneficial ownership of 4,096,621.40 shares of The Scotts Miracle-Gro Co. (SMG) common stock, which represents 7.0% of the class. The filing indicates that FMR LLC holds sole voting power over 4,072,438.45 shares and sole dispositive power over all 4,096,621.40 …

Oracle Corp Stock (ORCL) Opened Down by 3.14% on Aug 6: A Full Analysis

Oracle (ORCL) stock opened down by 3.14% on August 6 due to macroeconomic uncertainty, rising interest rate expectations, and scrutiny over Oracle Cloud Infrastructure (OCI) backlog conversion. Technical indicators show neutral momentum, while fundamental analysis highlights the company's strong revenue and net profit within …

What Pinnacle Financial Partners (PNFP)'s New Dividends and Bylaw Amendment Could Mean For Shareholders

Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates

Press Release: Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update

This press release from Aclaris Therapeutics announces its financial results for the second quarter of 2026, alongside corporate and clinical updates. The report will likely detail key financial metrics, provide insights into their ongoing clinical trials, and offer a broader corporate overview for investors …

Aclaris Therapeutics reports Q2 2026 net loss of $21.5M, cash runway through 2028

Aclaris Therapeutics reported a Q2 2026 net loss of $21.5 million, with cash, cash equivalents, and marketable securities totaling $170.6 million as of June 30, 2026. The company expects its cash runway, bolstered by an additional $40.2 million from ATM sales, to fund operations …

Earnings Flash (ACRS) Aclaris Therapeutics, Inc. Reports Q2 Revenue $1.6M, vs. FactSet Est of $1.4M

Aclaris Therapeutics, Inc. (ACRS) announced its Q2 revenue of $1.6 million, surpassing the FactSet estimate of $1.4 million. The biopharmaceutical company also recently received Fast-Track Designation for its inflammation treatment, Modzatinib, and was added to several Russell and S&P indices. The company is engaged …

Earnings Flash (ACRS) Aclaris Therapeutics Posts Q2 Net Loss $0.15 a Share, vs. FactSet Est of $0.16 Loss

Record Q2 growth and new $120M buyback at GigaCloud Technology (NASDAQ: GCT)

GigaCloud Technology Inc (NASDAQ: GCT) reported record second-quarter 2026 results with total revenue of $411.6 million, up 27.6% year-over-year, and net income of $42.3 million, up 22.3%. The company also announced a new three-year $120.0 million share repurchase program, replacing the remaining balance of …

GigaCloud Technology Inc Announces Second Quarter and Six Months Ended June 30, 2026 Financial Results

EL MONTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced financial results for the second quarter and six months ended June 30, …

Royal Bank of Canada Has $22.70 Million Stock Position in Pinnacle West Capital Corporation $PNW

Royal Bank of Canada increased its stake in Pinnacle West Capital Corporation by 6.5% in the first quarter, holding 225,298 shares valued at $22.7 million. Institutional investors collectively own 91.51% of PNW. The utility company reported mixed Q2 results with revenue up but EPS …

Scotts Miracle Gro (SMG) Could Be 18% Undervalued As SMG 2.0 Takes Shape

Oracle Corp (ORCL) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Aclaris Therapeutics (ACRS) Earnings Date and Reports 2026 $ACRS

GigaCloud Technology (Nasdaq: GCT) grows GMV to $1.74B and boosts profit

Pinnacle West (PNW) Stock Faces Profit Squeeze Despite Stronger Power Demand

Pinnacle West Capital (PNW) reported a profit squeeze in Q2 2026, with earnings per share down despite stronger power demand, driven by higher interest expenses and depreciation. While the company benefits from Arizona's growth, bears highlight concerns about rising costs and regulatory delays impacting …

Truist Financial Maintains Pinnacle West Capital Corp(PNW.US) With Hold Rating

Truist Financial has reiterated its Hold rating on Pinnacle West Capital Corp (PNW.US). This indicates that the firm advises investors to hold their current positions in the utility company rather than buying or selling.

Oracle Multi-VM Autonomous Database lands on Exadata systems

Oracle has expanded its Exadata Cloud at Customer service with a new Multi-VM Autonomous Database feature, allowing organizations to run both autonomous and non-autonomous Oracle databases on the same hardware. This virtualization, based on KVM hypervisor clustering, addresses customer demand for integrated database environments …

Pinnacle West Capital Q2 Earnings Call Highlights

Pinnacle West Capital reported Q2 2026 earnings of $1.43 per share, a $0.15 decrease year-over-year, despite strong demand and customer growth. The company expects to reach the high end of its $4.55–$4.75 earnings guidance for 2026, driven by significant customer expansion, especially from data …

Aclaris Therapeutics (NASDAQ: ACRS) CSO gets shares, some withheld

Aclaris Therapeutics' Chief Scientific Officer, Roland Kolbeck, had 36,375 restricted stock units vest, converting into common shares on August 1, 2026. Of these, 12,385 shares were withheld for tax obligations at $5.20 per share. Kolbeck still holds 109,125 RSUs that will vest in future …

Port data center site includes land sold by former Oracle executive

A former Oracle executive, George Roberts, was among the land sellers for a new hyperscale data center in Port Washington, Wisconsin, backed by Oracle. Roberts, who reported directly to Oracle founder Larry Ellison, sold 73.3 acres for $3.14 million for the project, which is …

Pinnacle Investment Earnings: Market Loves Growth but Miss What It Is Costing

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Scotts Miracle-Gro

Faruqi & Faruqi, LLP is investigating potential securities claims against The Scotts Miracle-Gro Company (NYSE: SMG) on behalf of investors who suffered losses exceeding $100,000 between November 3, 2021, and August 1, 2023. The firm alleges that Scotts made false or misleading statements regarding …

Aclara Resources Inc (ARA) Earnings Preview — What to Watch Before the Report

Pinnacle Investment Management Group Fiscal 2026 Adjusted Earnings, Revenue Up; Shares Jump 7%

Pinnacle West Capital Corp (PNW) (Q2 2026) Earnings Call Highlights: Robust Growth Offsets ...

This article first appeared on GuruFocus. Earnings Per Share (EPS): $1.43 in Q2 2026, a decrease of $0.15 compared to Q2 2025. Customer Growth: 2.1% increase compared to the second quarter of last year. Weather-Normalized Sales Growth: 9.6% increase compared to Q2 2025. Residential …

CACI International (NYSE: CACI) And Oracle (NYSE: ORCL) Win $400 Million Federal HR Modernization Contract With OPM

CACI International and Oracle have secured a 10-year, nearly $400 million contract with the U.S. Office of Personnel Management (OPM) for a federal HR IT modernization effort. This initiative aims to consolidate fragmented federal HR systems into a single, secure, cloud-based platform, expected to …

GUIDANCE: (PNW) Pinnacle West Capital Expects 2026 Consolidated EPS Range $4.55 to $4.75, Vs. FactSet Est of $4.73

Pinnacle West Capital Corporation (PNW) has provided its earnings per share (EPS) guidance for the fiscal year 2026. The company anticipates a consolidated EPS range of $4.55 to $4.75. This guidance compares to the current FactSet estimate of $4.73, suggesting the company's outlook is …